XGEN Venture is an Italian investment fund (SGR) established in 2021 by the former Genextra team, who have been active for over 15 years and have significant experience in the startup process, the discovery and the development of novel solutions for high unmet medical needs. The XGEN team is currently investing out of its first fund, XGEN Venture Life Science Fund launched at the end of 2022, while it continues to manage the Genextra portfolio.